Dr. Mehling was charged Dec. 20 with failing to pay employees’ payroll taxes to the IRS dating back to 2015 and using the money to travel and promote his stem cell research company.
In 2015, the IRS revoked the tax-exempt status of his consulting group, Blue Horizon Foundation, which he claims produced groundbreaking stem cell research.
The indictment also charged Dr. Mehling with failing to report a bank account in France, which contained more than $10,000 in 2018.
Prosecutors said Dr. Mehling owes the IRS $6 million.
More articles on orthopedics:
Dr. Nicholas Grosso on why his practice avoided PE investment and how consolidation will impact orthopedics
49 orthopedic devices receive FDA 510(k) clearance in November
2 recent orthopedic device company acquisitions — November
